| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.7 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.7 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |